PHILOGEN SPA (PHIL.MI) Stock Fundamental Analysis
Europe • Euronext Milan • BIT:PHIL • IT0005373789
21.15 EUR
+0.05 (+0.24%)
Last: Jan 30, 2026, 05:26 PM
We assign a fundamental rating of 7 out of 10 to PHIL. PHIL was compared to 85 industry peers in the Biotechnology industry. PHIL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PHIL is growing strongly while it is still valued neutral. This is a good combination! These ratings would make PHIL suitable for growth investing!
1. Profitability
1.1 Basic Checks
- In the past year PHIL was profitable.
- In the past year PHIL had a positive cash flow from operations.
- PHIL had negative earnings in 4 of the past 5 years.
- In the past 5 years PHIL reported 4 times negative operating cash flow.
1.2 Ratios
- PHIL has a better Return On Assets (28.81%) than 96.47% of its industry peers.
- PHIL has a Return On Equity of 36.49%. This is amongst the best in the industry. PHIL outperforms 95.29% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 21.08%, PHIL belongs to the top of the industry, outperforming 98.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 28.81% | ||
| ROE | 36.49% | ||
| ROIC | 21.08% |
ROA(3y)5.82%
ROA(5y)-1.99%
ROE(3y)6.79%
ROE(5y)-3.69%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 58.33%, PHIL belongs to the top of the industry, outperforming 96.47% of the companies in the same industry.
- PHIL's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 49.47%, PHIL belongs to the best of the industry, outperforming 97.65% of the companies in the same industry.
- The Gross Margin of PHIL (74.04%) is better than 61.18% of its industry peers.
- In the last couple of years the Gross Margin of PHIL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 49.47% | ||
| PM (TTM) | 58.33% | ||
| GM | 74.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y40.66%
GM growth 3YN/A
GM growth 5Y18.26%
2. Health
2.1 Basic Checks
- PHIL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for PHIL remains at a similar level compared to 1 year ago.
- The number of shares outstanding for PHIL has been reduced compared to 5 years ago.
- Compared to 1 year ago, PHIL has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 13.36 indicates that PHIL is not in any danger for bankruptcy at the moment.
- PHIL's Altman-Z score of 13.36 is amongst the best of the industry. PHIL outperforms 90.59% of its industry peers.
- PHIL has a debt to FCF ratio of 0.31. This is a very positive value and a sign of high solvency as it would only need 0.31 years to pay back of all of its debts.
- The Debt to FCF ratio of PHIL (0.31) is better than 89.41% of its industry peers.
- PHIL has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of PHIL (0.08) is better than 65.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.31 | ||
| Altman-Z | 13.36 |
ROIC/WACC2.6
WACC8.1%
2.3 Liquidity
- PHIL has a Current Ratio of 5.73. This indicates that PHIL is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of PHIL (5.73) is better than 84.71% of its industry peers.
- PHIL has a Quick Ratio of 5.52. This indicates that PHIL is financially healthy and has no problem in meeting its short term obligations.
- PHIL's Quick ratio of 5.52 is amongst the best of the industry. PHIL outperforms 85.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.73 | ||
| Quick Ratio | 5.52 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 255.77% over the past year.
- The Earnings Per Share has been growing by 100.72% on average over the past years. This is a very strong growth
- PHIL shows a strong growth in Revenue. In the last year, the Revenue has grown by 3346.54%.
- PHIL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.46% yearly.
EPS 1Y (TTM)255.77%
EPS 3YN/A
EPS 5Y100.72%
EPS Q2Q%3.48%
Revenue 1Y (TTM)3346.54%
Revenue growth 3Y209.5%
Revenue growth 5Y42.46%
Sales Q2Q%606.29%
3.2 Future
- Based on estimates for the next years, PHIL will show a decrease in Earnings Per Share. The EPS will decrease by -3.40% on average per year.
- Based on estimates for the next years, PHIL will show a very strong growth in Revenue. The Revenue will grow by 22.55% on average per year.
EPS Next Y14.73%
EPS Next 2Y-53.92%
EPS Next 3Y-63.96%
EPS Next 5Y-3.4%
Revenue Next Year112.03%
Revenue Next 2Y-23.41%
Revenue Next 3Y-35.23%
Revenue Next 5Y22.55%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 18.55, the valuation of PHIL can be described as rather expensive.
- Based on the Price/Earnings ratio, PHIL is valued cheaply inside the industry as 87.06% of the companies are valued more expensively.
- PHIL is valuated rather cheaply when we compare the Price/Earnings ratio to 28.30, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 16.93 indicates a correct valuation of PHIL.
- 85.88% of the companies in the same industry are more expensive than PHIL, based on the Price/Forward Earnings ratio.
- PHIL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.55 | ||
| Fwd PE | 16.93 |
4.2 Price Multiples
- 89.41% of the companies in the same industry are more expensive than PHIL, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, PHIL is valued cheaper than 91.76% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.8 | ||
| EV/EBITDA | 10.22 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of PHIL may justify a higher PE ratio.
- PHIL's earnings are expected to decrease with -63.96% in the coming years. This may justify a cheaper valuation.
PEG (NY)1.26
PEG (5Y)0.18
EPS Next 2Y-53.92%
EPS Next 3Y-63.96%
5. Dividend
5.1 Amount
- No dividends for PHIL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PHILOGEN SPA / PHIL.MI FAQ
What is the fundamental rating for PHIL stock?
ChartMill assigns a fundamental rating of 7 / 10 to PHIL.MI.
What is the valuation status for PHIL stock?
ChartMill assigns a valuation rating of 6 / 10 to PHILOGEN SPA (PHIL.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for PHILOGEN SPA?
PHILOGEN SPA (PHIL.MI) has a profitability rating of 6 / 10.
What is the expected EPS growth for PHILOGEN SPA (PHIL.MI) stock?
The Earnings per Share (EPS) of PHILOGEN SPA (PHIL.MI) is expected to grow by 14.73% in the next year.